0001367644-20-000134.txt : 20200812
0001367644-20-000134.hdr.sgml : 20200812
20200812165250
ACCESSION NUMBER: 0001367644-20-000134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200811
FILED AS OF DATE: 20200812
DATE AS OF CHANGE: 20200812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOULWAN GEORGE A
CENTRAL INDEX KEY: 0001222197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 201096009
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_159726555510283.xml
FORM 4
X0306
4
2020-08-11
0
0001367644
Emergent BioSolutions Inc.
EBS
0001222197
JOULWAN GEORGE A
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2020-08-11
4
S
0
6000
124.1059
D
26771
D
Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $121.78 to $125.14.
/s/ S. Scott Lieberman, Attorney-in-fact
2020-08-12